List view / Grid view
In this supplement, we've brought together a collection of interesting posters from leading companies in order to celebrate cutting-edge research in the pharmaceutical industry and to share with our readers some of the varied work being carried out by their colleagues...
Just under a quarter (22%) of life science companies already using or experimenting with blockchain, but industry collaboration over security and storage standards is needed…
The Global Access to Healthcare Index measures how healthcare systems across 60 countries are working to solve the most pressing healthcare needs...
A new deal on the breast cancer drug trastuzumab emtansine means that it can now be recommended for routine funding.
A new report released by the UK BioIndustry Association (BIA) shows that the UK maintained its strong leadership position in European biotech funding last year and has the strongest pipeline in Europe for future drug development.
Health leaders announced the launch of the Alliance for Transparent & Affordable Prescriptions (ATAP), a coalition of provider and patient groups concerned about the practices of pharmacy benefit managers (PBMs) driving up drug costs.
In a study of 10 high-income countries with universal health care, costs for prescription drugs in 6 of the largest categories varied by more than 600%.
Diagnostic tests can help identify disease and disease probability in patients, leading to earlier treatment, but what’s the real cost?
Biotech and pharmaceutical firms hold vast amounts of valuable data and information making them prime targets for cyber-attacks – so how are they protecting themselves?
10 April 2017 | By Guillaume Roussel, Director of Strategy, Veeva OpenData, Europe, Veeva Systems
Veeva's Guillaume Roussel explains how customer data can create personalised multichannel communication with healthcare professionals in the industry...
Thermo Fisher Scientific Inc., the world leader in serving science, announced that it has acquired Core Informatics, which provides a leading cloud-based platform supporting scientific data management.
1 February 2017 | By Jurgi Camblong (CEO, Sophia Genetics)
Sophia Genetics co-founder and CEO, Jurgi Camblong, tackles issues of privacy and security for healthcare patient data...
22 November 2016 | By Monica McDonnell, Informatica
Informatica's Monica McDonnell gives the lowdown on the Identification of Medicinal Products new regulations and how to manage big data all across Europe...
13 June 2013 | By Payal Roychoudhury, formerly AstraZeneca and Ronan O’Kennedy, Fujifilm Diosynth Biotechologies and Jim Faulkner, GlaxoSmithKline and Brian McNeil & Linda M. Harvey, University of Strathclyde
Biopharmaceutical companies are constantly evaluating new methods for mammalian cell line development that offer benefits such as shorter time lines, improved consistency, higher monoclonal antibody (mAb) production, better genetic stability and increased flexibility. Each of these advantages extends a potentially large cost benefit to companies as their recombinant protein products…
As health care systems around the world face challenges such as labor shortages, increased regulation and budget constraints, they rely on technology to help manage the impact. To assist in addressing these challenges, today Abbott announced OneLab, a new, Web-based, integrated laboratory informatics solution.
